title: 'Lower anti-drug antibodies with etanercept biosimilar: can Ctrough explain the differences?'.
authors.forename: Chirag A
authors.initials: CA
authors.lastname: Shah
mesh_terms: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D059451:Biosimilar Pharmaceuticals; D000068800:Etanercept; D007074:Immunoglobulin G; D000069285:Infliximab; D018124:Receptors, Tumor Necrosis Factor
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D059451:Biosimilar Pharmaceuticals; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000069285:Infliximab; D000068800:Etanercept
keywords: Disease Activity; Infections; Treatment